{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:33:09Z","timestamp":1767889989003,"version":"3.49.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The epidemiology of community-acquired pneumonia (CAP) has changed, influenced by sociosanitary conditions and vaccination status. We aimed to analyze the recent epidemiology of bacterial CAP in hospitalized children in a setting with high pneumococcal vaccination coverage and to describe the clinical characteristics of pediatric <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> CAP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Children &lt;17 years old hospitalized from 2008 to 2018 with bacterial CAP in 5 tertiary hospitals in Spain were included. Cases with pneumococcal CAP were randomly selected as comparative group following a case-control ratio of 2:1 with <jats:italic toggle=\"yes\">S. aureus<\/jats:italic> CAP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 313 bacterial CAP were diagnosed: <jats:italic toggle=\"yes\">Streptococcus pneumoniae<\/jats:italic> CAP (n = 236, 75.4%), <jats:italic toggle=\"yes\">Streptococcus pyogenes<\/jats:italic> CAP (n = 43, 13.7%) and <jats:italic toggle=\"yes\">S. aureus<\/jats:italic> CAP (n = 34, 10.9%). Throughout the study period, the prevalence of <jats:italic toggle=\"yes\">S. pyogenes<\/jats:italic> increased (annual percentage change: +16.1% [95% CI: 1.7\u201332.4], <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.031), <jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic> decreased (annual percentage change: \u20134.4% [95 CI: \u20138.8 to 0.2], <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.057) and <jats:italic toggle=\"yes\">S. aureus<\/jats:italic> remained stable. Nine isolates of <jats:italic toggle=\"yes\">S. aureus<\/jats:italic> (26.5%) were methicillin-resistant. Seventeen cases (50%) with <jats:italic toggle=\"yes\">S. aureus<\/jats:italic> CAP had some pulmonary complication and 21 (61.7%) required intensive care. <jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic> CAP showed a trend toward higher prevalence of pulmonary complications compared with <jats:italic toggle=\"yes\">S. aureus<\/jats:italic> CAP (69.1% vs. 50.0%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.060), including higher frequency of pulmonary necrosis (32.4% vs. 5.9%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.003).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The incidence of <jats:italic toggle=\"yes\">S. aureus<\/jats:italic> CAP in children remained stable, whereas the prevalence of pneumococcal CAP decreased and <jats:italic toggle=\"yes\">S. pyogenes<\/jats:italic> CAP increased. Patients with <jats:italic toggle=\"yes\">S. aureus<\/jats:italic> presented a high frequency of severe outcomes, but a lower risk of pulmonary complications than patients with <jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003503","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T19:00:20Z","timestamp":1648234820000},"page":"e235-e242","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Staphylococcus aureus Community-acquired Pneumonia in Children After 13-Valent Pneumococcal Vaccination (2008\u20132018): Epidemiology, Clinical Characteristics and Outcomes"],"prefix":"10.1097","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1017-2386","authenticated-orcid":false,"given":"David","family":"Aguilera-Alonso","sequence":"first","affiliation":[{"name":"Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Unidad de Investigaci\u00f3n Materno-Infantil Fundaci\u00f3n Familia Alonso (UDIMIFFA), Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM), Madrid, Spain"},{"name":"CIBER en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4143-3438","authenticated-orcid":false,"given":"Silke","family":"Kirchschl\u00e4ger Nieto","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Centro de Salud, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7287-882X","authenticated-orcid":false,"given":"Mar\u00eda F\u00e1tima","family":"Ara Montojo","sequence":"additional","affiliation":[{"name":"Pediatric Department, Hospital Universitario Quironsalud, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Jos\u00e9","family":"Sanz Santaeufemia","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Saavedra-Lozano","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Unidad de Investigaci\u00f3n Materno-Infantil Fundaci\u00f3n Familia Alonso (UDIMIFFA), Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM), Madrid, Spain"},{"name":"CIBER en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Soto","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital de Getafe, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Caminoa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital de Torrej\u00f3n, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3324-6520","authenticated-orcid":false,"given":"Arantxa","family":"Berzosa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Clinico San Carlos, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Prieto Tato","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Hospital Universitario Doce de Octubre, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Cercenado","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, CIBERES, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2860-3455","authenticated-orcid":false,"given":"Alfredo","family":"Tagarro","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Infanta Sof\u00eda, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Molina Arana","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Hospital de Getafe, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Alonso Sanz","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Pilar","family":"Romero G\u00f3mez","sequence":"additional","affiliation":[{"name":"CIBER en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"},{"name":"Department of Microbiology, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Chaves S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Baquero-Artigao","sequence":"additional","affiliation":[{"name":"CIBER en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(20)31550-6","article-title":"Complicated pneumonia in children.","volume":"396","author":"de Benedictis","year":"2020","journal-title":"Lancet"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2019.03.015","article-title":"Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15\u202fyears old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study.","volume":"37","author":"Picazo","year":"2019","journal-title":"Vaccine"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/cid\/cix115","article-title":"Pneumococcal pneumonia requiring hospitalization in US children in the 13-valent pneumococcal conjugate vaccine era.","volume":"64","author":"Olarte","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jpids\/piy103","article-title":"Change in bacterial causes of community-acquired Parapneumonic effusion and pleural empyema in children 6 years after 13-valent pneumococcal conjugate vaccine implementation.","volume":"8","author":"Madhi","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S2213-2600(16)00096-5","article-title":"Aetiology of childhood pneumonia in a well vaccinated South African birth cohort: a nested case-control study of the Drakenstein Child Health Study.","volume":"4","author":"Zar","year":"2016","journal-title":"Lancet Respir Med"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cmi.2018.10.020","article-title":"Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010-2017: a nationwide surveillance study.","volume":"25","author":"Liese","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"576519","DOI":"10.3389\/fped.2020.576519","article-title":"Outcome of severe bacterial pneumonia in the era of pneumococcal vaccination.","volume":"8","author":"Del Rosal","year":"2020","journal-title":"Front Pediatr"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/cid\/cir625","article-title":"Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"suppl 2)","key":"R9-20250615","first-page":"ii1","article-title":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011.","volume":"66","author":"Harris","year":"2011","journal-title":"Thorax"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America.","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study.","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.puhe.2020.06.007","article-title":"Invasive group A streptococcal infections in North West England: epidemiology, risk factors and fatal infection.","volume":"186","author":"Blagden","year":"2020","journal-title":"Public Health"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3201\/eid2702.201945","article-title":"Increasing incidence of invasive Group A Streptococcus disease in first nations population, Alberta, Canada, 2003-2017.","volume":"27","author":"Tyrrell","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.anpedi.2018.12.017","article-title":"[Invasive disease due to Streptococcus pyogenes: Changes in incidence and prognostic factors].","volume":"91","author":"Su\u00e1rez-Arrabal","year":"2019","journal-title":"An Pediatr (Engl Ed)"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"217.e1","DOI":"10.1016\/j.anpedi.2014.12.002","article-title":"[Community acquired pneumonia in children: Treatment of complicated cases and risk patients. Consensus statement by the Spanish Society of Paediatric Infectious Diseases (SEIP) and the Spanish Society of Paediatric Chest Diseases (SENP)].","volume":"83","author":"Moreno-P\u00e9rez","year":"2015","journal-title":"An Pediatr (Barc)"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/cid\/ciy495","article-title":"Vancomycin monotherapy may be insufficient to treat Methicillin-resistant Staphylococcus aureus coinfection in children with influenza-related critical illness.","volume":"68","author":"Randolph","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ppul.21269","article-title":"Community-acquired Staphylococcus aureus pneumonia among hospitalized children in Hawaii.","volume":"45","author":"Len","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/INF.0b013e31821618be","article-title":"Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children\u2019s Hospital.","volume":"30","author":"Carrillo-Marquez","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s10096-016-2651-7","article-title":"Community-associated Staphylococcus aureus pneumonia among Greek children: epidemiology, molecular characteristics, treatment, and outcome.","volume":"35","author":"Doudoulakakis","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.2147\/IDR.S282880","article-title":"Staphylococcus aureus nasal colonization in Spanish children. The COSACO Nationwide Surveillance Study.","volume":"13","author":"Rosal","year":"2020","journal-title":"IDR"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jinf.2020.10.032","article-title":"Methicillin-susceptible staphylococcus aureus in community-acquired pneumonia: risk factors and outcomes.","volume":"82","author":"Cilloniz","year":"2021","journal-title":"J Infect"},{"key":"R26-20250615","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"848","DOI":"10.12788\/jhm.3093","article-title":"Prevalence of Staphylococcus aureus and use of antistaphylococcal therapy in children hospitalized with pneumonia.","volume":"13","author":"Frush","year":"2018","journal-title":"J Hosp Med"},{"key":"R28-20250615","doi-asserted-by":"crossref","first-page":"e20183090","DOI":"10.1542\/peds.2018-3090","article-title":"Prevalence, risk factors, and outcomes of bacteremic pneumonia in children.","volume":"144","author":"Fritz","year":"2019","journal-title":"Pediatrics"},{"key":"R29-20250615","first-page":"11","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus pneumonia in a children\u2019s hospital. Our ten-year experience.","volume":"119","author":"Ensinck","year":"2021","journal-title":"Arch Argent Pediatr"},{"key":"R30-20250615","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/cid\/ciw300","article-title":"Staphylococcus aureus community-acquired pneumonia: prevalence, clinical characteristics, and outcomes.","volume":"63","author":"Self","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R31-20250615","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/INF.0000000000002699","article-title":"Characteristics of Streptococcus pyogenes versus Streptococcus pneumoniae pleural empyema and pneumonia with pleural effusion in children.","volume":"39","author":"Megged","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R32-20250615","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1097\/INF.0000000000002474","article-title":"Increasing rates of pediatric empyema and disease severity with predominance of serotype 3 S. pneumonia: an Australian single-center, retrospective cohort 2011 to 2018.","volume":"38","author":"Haggie","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"R33-20250615","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpeds.2018.12.002","article-title":"Risk factors for complications in children with Staphylococcus aureus bacteremia.","volume":"208","author":"Hamdy","year":"2019","journal-title":"J Pediatr"},{"key":"R34-20250615","first-page":"ciab510","article-title":"Pediatric Staphylococcus aureus bacteremia: clinical spectrum and predictors of poor outcome.","author":"Campbell","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R35-20250615","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eimc.2018.02.005","article-title":"Pediatric case of fatal necrotizing pneumonia due to Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus in Spain.","volume":"37","author":"Mosquera","year":"2019","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"R36-20250615","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.eimc.2020.01.018","article-title":"Therapy of Staphylococcus aureus bacteremia: evidences and challenges.","volume":"38","author":"L\u00f3pez-Cort\u00e9s","year":"2020","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"R37-20250615","doi-asserted-by":"crossref","first-page":"643.e1","DOI":"10.1016\/j.cmi.2016.04.004","article-title":"Factors associated with severity in invasive community-acquired Staphylococcus aureus infections in children: a prospective European multicentre study.","volume":"22","author":"Gij\u00f3n","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R38-20250615","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S1473-3099(16)30267-5","article-title":"Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study.","volume":"16","author":"Aliberti","year":"2016","journal-title":"Lancet Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:03:15Z","timestamp":1750003395000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003503","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,8]]}}}